George Salti, MD
Surgical Oncology · Naperville, ILNPI 1306847702
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medtronic at 42.2% of the total. 2025 is the largest year on record at $2,904, more than ten times the $49 reported in 2019.
Across 28 payments — averaging $134.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Histosonics, Inc.$1K
- Johnson & Johnson$466
- Intera Oncology, Inc$236
- Angiodynamics, Inc.$115
- W. L. Gore & Associates, Inc.$106
- plus $186 from 5 others
What the payments were for
- Speaking & faculty fees$1,18031%
- Travel & lodging$83822%
- Food & beverage$1,72046%
- Education$221%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 6 | $1,587 |
| Histosonics, Inc. | 2 | $1,063 |
| Johnson & Johnson | 10 | $466 |
| Intera Oncology, Inc | 2 | $236 |
| Angiodynamics, Inc. | 1 | $115 |
| W. L. Gore & Associates, Inc. | 2 | $106 |
| Mentor Worldwide LLC | 1 | $80 |
| Davol Inc. | 1 | $49 |
| AbbVie | 1 | $22 |
| Conmed Corporation | 1 | $21 |
| Polynovo North America LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Signia$1,180
- INTERA$151
- Nanoknife$115
- VISTASEAL$112
- ECHELON FLEX Stapler$112
How this compares
$3,760 in reported general payments places this provider in the 60th percentile of 55 surgical oncology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 12 | $232 |
| Metoprolol Tartrate | 12 | $115 |
| Neomycin Sulfate | 15 | $77 |
| Metronidazole | 16 | $28 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Naperville
- Fadi DahdalehChicago$198K
- Claudius ConradUrbana$174K
- Nora HansenChicago$41K
- Jeffrey WayneChicago$38K
- David BentremChicago$34K
- Mecker MollerChicago$25K
- Akhil ChawlaWarrenville$17K
- Shishir MaithelChicago$16K
- Ashley HardyWarrenville$16K
- Aslam EjazChicago$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.